muraglitazar has been researched along with ly 465608 in 1 studies
| Studies (muraglitazar) | Trials (muraglitazar) | Recent Studies (post-2010) (muraglitazar) | Studies (ly 465608) | Trials (ly 465608) | Recent Studies (post-2010) (ly 465608) |
|---|---|---|---|---|---|
| 85 | 10 | 25 | 7 | 0 | 0 |
| Protein | Taxonomy | muraglitazar (IC50) | ly 465608 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.548 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.174 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.548 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.548 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henke, BR | 1 |
1 review(s) available for muraglitazar and ly 465608
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |